Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 75
Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements
Gautam Sethi, Prangya Rath, Abhishek Chauhan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 712-712
Open Access | Times Cited: 69
Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
Xiangying Yan, Yudong Liu, Congchong Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 13
ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT Pathway
Munetoshi Akaoka, Mitsuru Yanagaki, Hoshiho Kubota, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 3009-3018
Closed Access | Times Cited: 1
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism
Chun‐Cheng Yang, Yu‐Chuan Yan, Guo‐Qiang Pan, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 20
Protective efficacy of Schizandrin B on ameliorating nephrolithiasis via regulating GSK3β/Nrf2 signaling-mediated ferroptosis in vivo and in vitro
Caitao Dong, Chao Song, Ziqi He, et al.
International Immunopharmacology (2023) Vol. 117, pp. 110042-110042
Closed Access | Times Cited: 19
Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma
Weifeng Hong, Yang Zhang, Siwei Wang, et al.
Cancer Letters (2023) Vol. 582, pp. 216594-216594
Closed Access | Times Cited: 18
Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis
Ting Li, Haiyan Huang, Bo Qian, et al.
Free Radical Biology and Medicine (2024) Vol. 212, pp. 360-374
Closed Access | Times Cited: 7
DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion
Xinyu Mei, Jinfeng Xiong, Jian Liu, et al.
Cancer Letters (2024) Vol. 584, pp. 216609-216609
Open Access | Times Cited: 7
RBBP7, regulated by SP1, enhances the Warburg effect to facilitate the proliferation of hepatocellular carcinoma cells via PI3K/AKT signaling
Yuan Fang, Weiqiang Tang, Siming Qu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation
Shuai Yan, Lu Chen, Hao Zhuang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3046-3060
Open Access | Times Cited: 6
Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma
Mubarak A. Alamri
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 1125-1138
Open Access | Times Cited: 11
Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling
Jian Yang, Jialuo He, Yiting Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Histone deacetylase 6 deficiency protects the liver against ischemia/reperfusion injury by activating PI3K/AKT/mTOR signaling
Jie Pan, Q C Yu, Yaodong Song, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 4
Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review
Gagandeep Kaur, Sushma Devi, Akhil Sharma, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3057-3077
Closed Access | Times Cited: 4
Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
Fatima Zohra Mokhfi, Md. Al Amin, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2024) Vol. 402, pp. 111218-111218
Closed Access | Times Cited: 4
PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
Zhenxiong Zhao, Hui Sun, Yingxue Liu, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
FBXO22 promotes HCC angiogenesis and metastasis via RPS5/AKT/HIF-1α/VEGF-A signaling axis
Zhen Lei, Yiming Luo, Junli Lu, et al.
Cancer Gene Therapy (2025)
Open Access
In vitro evaluation of silver-zinc oxide-eugenol nanocomposite for enhanced antimicrobial and wound healing applications in diabetic conditions
Hari Prasath Nagaiah, Malik Basha Samsudeen, Akshaya Rani Augustus, et al.
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
The Role of Chemokine (C‐C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms
Yangkun Luo, Fei Wan, Zhao Zhang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Pea Peptide Modulates Abnormal Aβ Production in PC12 Cells Induced by Lead Exposure
Ning Li, Ningning Cui, Ibrahim A. Bakry, et al.
Plant Foods for Human Nutrition (2025) Vol. 80, Iss. 2
Closed Access
Exploration of Mechanism of Bufalin and Bufalin Derivatives in Hepatocellular Carcinoma
Xinchen Gao, Tong-hua Bian, Xinyu Wei, et al.
Phytomedicine (2025), pp. 156686-156686
Closed Access
Page 1 - Next Page

Scroll to top